Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys.

Xiao YF, Wang B, Wang X, Du F, Benzinou M, Wang YX.

BMC Anesthesiol. 2013 Oct 20;13(1):33. doi: 10.1186/1471-2253-13-33.

2.

Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: mechanisms and implications for preclinical models.

Saha JK, Xia J, Grondin JM, Engle SK, Jakubowski JA.

Exp Biol Med (Maywood). 2005 Nov;230(10):777-84.

PMID:
16246906
3.

Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs.

Rashid S, Shi ZQ, Niwa M, Mathoo JM, Vandelangeryt ML, Bilinski D, Lewis GF, Vranic M.

Diabetes. 2000 Feb;49(2):253-62.

PMID:
10868942
4.

Anesthetic-induced transient hyperglycemia and insulin resistance do not depend on the sympathoadrenal axis.

De Oliveira JC, Ludemann Camargo R, Barella LF, Chaves Souto Branco R, Gravena C, Grassiolli S, Torrezan R, Cezar De Freitas Mathias P.

Minerva Endocrinol. 2013 Dec;38(4):379-88.

PMID:
24285105
5.

Glucagon-like peptide-1 has no insulin-like effects in insulin-dependent diabetic dogs maintained normoglycemic and normoinsulinemic.

Freyse EJ, Knospe S, Becher T, El Hag O, Göke B, Fischer U.

Metabolism. 1999 Jan;48(1):134-7.

PMID:
9920158
6.

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.

PMID:
10909980
7.

A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.

Saha JK, Xia J, Engle SK, Chen YF, Glaesner W, Jakubowski JA.

J Pharmacol Exp Ther. 2006 Mar;316(3):1159-64. Epub 2005 Nov 9.

8.

Evidence that carotid bodies play an important role in glucoregulation in vivo.

Koyama Y, Coker RH, Stone EE, Lacy DB, Jabbour K, Williams PE, Wasserman DH.

Diabetes. 2000 Sep;49(9):1434-42.

PMID:
10969826
9.
10.
11.
12.

Hyperglycemia and hypoinsulinemia during xylazine-ketamine anesthesia in Thoroughbred horses.

Tranquilli WJ, Thurmon JC, Neff-Davis CA, Davis LE, Benson GJ, Hoffman W, Lock TF.

Am J Vet Res. 1984 Jan;45(1):11-4.

PMID:
6367557
13.

Effect of yohimbine on xylazine-induced hypoinsulinemia and hyperglycemia in mares.

Greene SA, Thurmon JC, Tranquilli WJ, Benson GJ.

Am J Vet Res. 1987 Apr;48(4):676-8.

PMID:
3296886
14.
15.

The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.

Sakurai H, Dobbs RE, Unger RH.

Metabolism. 1975 Nov;24(11):1287-97.

PMID:
1186499
17.

Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.

Acerini CL, Harris DA, Matyka KA, Watts AP, Umpleby AM, Russell-Jones DL, Dunger DB.

Metabolism. 1998 Dec;47(12):1481-9.

PMID:
9867078
18.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
19.
20.

Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Saccà L, Cicala M, Trimarco B, Ungaro B, Vigorito C.

J Clin Invest. 1982 Jul;70(1):117-26.

Items per page

Supplemental Content

Write to the Help Desk